IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
- 15 November 2011
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 20 (5), 661-673
- https://doi.org/10.1016/j.ccr.2011.10.012
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cell cycle regulation in hematopoietic stem cellsThe Journal of cell biology, 2011
- BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibitionNature, 2011
- A novel tumour-suppressor function for the Notch pathway in myeloid leukaemiaNature, 2011
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activityJCI Insight, 2011
- Chronic myeloid leukemia: mechanisms of blastic transformationJCI Insight, 2010
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib MesylateCancer Cell, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- Lin28 promotes transformation and is associated with advanced human malignanciesNature Genetics, 2009
- JunB Protects against Myeloid Malignancies by Limiting Hematopoietic Stem Cell Proliferation and Differentiation without Affecting Self-RenewalCancer Cell, 2009
- Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph + leukemia in miceProceedings of the National Academy of Sciences of the United States of America, 2006